Avalyn Pharma Inc. (AVLN)
NMS · Healthcare · Biotechnology
$27.25
+8.52%
Closing price as of 2026-10-22 · Source: TEK2day Finance
Key Metrics
Market Cap
$1.21B
Shares Outstanding
44.3M
Exchange
NMS
Currency
USD
Quarterly Financials
| Metric | 2025-03-31 | 2025-06-30 | 2026-03-31 | 2026-06-30 |
|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | (18.7M) | (21.8M) | (27.9M) | (31.3M) |
| Net Income | (17.5M) | (20.2M) | (26.9M) | (28.9M) |
| Diluted EPS | $-0.42 | $-0.48 | $-0.64 | $-0.65 |
Annual Financials
| Metric | 2024-12-31 | 2025-12-31 |
|---|---|---|
| Revenue | 0.00 | 0.00 |
| Operating Income | (57.1M) | (91.3M) |
| Net Income | (49.7M) | (85.2M) |
| Diluted EPS | $-1.19 | $-2.04 |